Work

The role of ageing in polyglutamine-induced neurodegeneration. A study in Machado-Joseph disease models

Year: 2019
Type: dissertation
Abstract: Machado-Joseph disease (MJD) or Spinocerebellar Ataxia Type 3 (SCA3) is an autosomal dominantly-inherited neurodegenerative disorder characterized by the pathological expansion of the CAG trinucleotide tract within the coding sequence of the ATXN3/MJD1 gene, conferring a toxic gain-of-function to the resulting mutant ataxin-3 protein. It belongs to the polyglutamine group of diseases, being the most common dominantly-inherited ataxia worldwide. The mutant protein leads to neuronal dysfunction and neurodegeneration in specific brain regions, with symptoms manifesting at midlife. Despite the significant research advances over the last years, the molecular mechanisms involved in MJD are still unclear and no treatment able to modify disease progression is available to patients. Ageing is the major risk factor for neurodegenerative disorders, being associated with the occurrence and progression of Alzheimer’s, Huntington’s and Parkinson’s disease, among others. Nuclear lamins and other proteins that are linked to homeostasis, have been shown to be altered not only in normal ageing, but also in neurodegenerative diseases. Furthermore, progerin, a mutated form of lamin A/C, responsible for the premature and accelerated ageing phenotype of Hutchinson-Gilford Progeria Syndrome, constitutes a good model to study specific ageing characteristics. The main aim of this project was to investigate the role of ageing in MJD. In the first part of the work, detailed in chapter 2, we investigated the presence of age-related markers in MJD cellular (patient fibroblasts, N2a cells) and mouse models (transgenic and lentiviral models). A decrease in the protein levels of Lamins B1 and C, together with decreased Zmpste24 (involved in the maturation of lamin A) mRNA and protein levels was observed in the different MJD models. Moreover, we also observed nuclear circularity abnormalities, a hallmark of ageing, in the N2a MJD model, suggestive of an age-related phenotype. These results suggest that ageing might have a relevant role in MJD pathogenesis. To address the role of ageing in MJD degeneration, as detailed in chapter 3, we overexpressed progerin in a relevant brain area (the striatum) of a MJD lentiviral mouse model. Progerin overexpression aggravated MJD neuropathology, increasing loss of DARPP-32 expression, along with increased number of ubiquitinated aggregates. A tendency to increase the number of pyknotic nuclei was also seen, together with a significant increase in reactive astrogliosis. Taking all the above-mentioned evidences into account, we may infer that ageing may play an important role aggravating MJD pathogenesis and associated neuroinflammation. Finally, in chapter 4, having in mind that accelerating ageing aggravated the MJD- associated neuropathology, we further investigated whether this could be rescued by blocking progerin expression and delaying ageing in transgenic mice that recapitulates HGPS - Lmna G609G/ G609G, using the same strategy for the striatal MJD lentiviral model described in chapter 3, but using a shRNA targeting Lmna/progerin transcripts’ 3’UTR, together with mutant ataxin-3 lentiviral-induced expression. In this part of the work we were not able to detect any change in DARPP-32 depleted volume among the hemispheres as well as no alteration in mutant ataxin-3 aggregated protein levels. Given that the downregulation of progerin levels in this transgenic mouse model was limited, further studies are necessary to draw conclusions from this study In summary, this thesis provides strong evidences that ageing may have a relevant role in MJD, aggravating its associated neuropathological features. Delaying ageing, might be a possible strategy to delay neurodegeneration associated to MJD, a strategy for which more studies are needed.
Author: Dina Pereira
Language: English
Open Access status: green
OpenAlex ID: W3082094375
Cites: 494
Cited by:
Related to: 10